Literature DB >> 21784893

Identification of the nephropathy-susceptibility locus HIVAN4.

Sindhuri Prakash1, Natalia Papeta, Roel Sterken, Zongyu Zheng, Robert L Thomas, Zhenzhen Wu, John R Sedor, Vivette D D'Agati, Leslie A Bruggeman, Ali G Gharavi.   

Abstract

HIVAN1, HIVAN2, and HIVAN3 are nephropathy-susceptibility loci previously identified in the HIV-1 transgenic mouse, a model of collapsing glomerulopathy. The HIVAN1 and HIVAN2 loci modulate expression of Nphs2, which encodes podocin and several other podocyte-expressed genes. To identify additional loci predisposing to nephropathy, we performed a genome-wide scan in 165 backcross mice generated between the nephropathy-sensitive HIV-1-transgenic FVB/NJ (TgFVB) strain and the resistant Balb/cJ (BALB) strain. We identified a major susceptibility locus (HIVAN4) on chromosome 6 G3-F3, with BALB alleles conferring a twofold reduction in severity (peak LOD score = 4.0). Similar to HIVAN1 and HIVAN2, HIVAN4 modulated expression of Nphs2, indicating a common pathway underlying these loci. We independently confirmed the HIVAN4 locus in a sister TgFVB colony that experienced a dramatic loss of nephropathy subsequent to a breeding bottleneck. In this low-penetrance line, 3% of the genome was admixed with BALB alleles, suggesting a remote contamination event. The admixture localized to discrete segments on chromosome 2 and at the HIVAN4 locus. HIVAN4 candidate genes include killer lectin-like receptor genes as well as A2m and Ptpro, whose gene products are enriched in the glomerulus and interact with HIV-1 proteins. In summary, these data identify HIVAN4 as a major quantitative trait locus for nephropathy and a transregulator of Nphs2. Furthermore, similar selective breeding strategies may help identify further susceptibility loci.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784893      PMCID: PMC3148704          DOI: 10.1681/ASN.2011020209

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  36 in total

1.  Haplotype mapping indicates two independent origins for the Cmv1s susceptibility allele to cytomegalovirus infection and refines its localization within the Ly49 cluster.

Authors:  S H Lee; J Gitas; A Zafer; P Lepage; T J Hudson; A Belouchi; S M Vidal
Journal:  Immunogenetics       Date:  2001-08       Impact factor: 2.846

2.  The mosaic structure of variation in the laboratory mouse genome.

Authors:  Claire M Wade; Edward J Kulbokas; Andrew W Kirby; Michael C Zody; James C Mullikin; Eric S Lander; Kerstin Lindblad-Toh; Mark J Daly
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

3.  alpha 2-Macroglobulin is cleaved by HIV-1 protease in the bait region but not in the C-terminal inter-domain region.

Authors:  U C Meier; A Billich; K Mann; H J Schramm; W Schramm
Journal:  Biol Chem Hoppe Seyler       Date:  1991-12

4.  Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy.

Authors:  B I Freedman; J M Soucie; S M Stone; S Pegram
Journal:  Am J Kidney Dis       Date:  1999-08       Impact factor: 8.860

5.  NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy.

Authors:  Michael J Ross; Scott Martinka; Vivette D D'Agati; Leslie A Bruggeman
Journal:  J Am Soc Nephrol       Date:  2005-06-23       Impact factor: 10.121

6.  Nuclear factor-kappa B binding to the HIV-1 LTR in kidney: implications for HIV-associated nephropathy.

Authors:  L A Bruggeman; S H Adler; P E Klotman
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

7.  Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate.

Authors:  B L Wharram; M Goyal; P J Gillespie; J E Wiggins; D B Kershaw; L B Holzman; R C Dysko; T L Saunders; L C Samuelson; R C Wiggins
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

8.  Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes.

Authors:  J B Kopp; M E Klotman; S H Adler; L A Bruggeman; P Dickie; N J Marinos; M Eckhaus; J L Bryant; A L Notkins; P E Klotman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways.

Authors:  John Cijiang He; Mohammad Husain; Masaaki Sunamoto; Vivette D D'Agati; Mary E Klotman; Ravi Iyengar; Paul E Klotman
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

10.  Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3.

Authors:  Ali G Gharavi; Tariq Ahmad; Robert D Wong; Roozbeh Hooshyar; Janene Vaughn; Sarah Oller; Rachelle Z Frankel; Leslie A Bruggeman; Vivette D D'Agati; Paul E Klotman; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

View more
  7 in total

1.  Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.

Authors:  Meredith A Bostrom; W H Linda Kao; Man Li; Hanna E Abboud; Sharon G Adler; Sudha K Iyengar; Paul L Kimmel; Robert L Hanson; Susanne B Nicholas; Rebekah S Rasooly; John R Sedor; Josef Coresh; Orly F Kohn; David J Leehey; Denyse Thornley-Brown; Erwin P Bottinger; Michael S Lipkowitz; Lucy A Meoni; Michael J Klag; Lingyi Lu; Pamela J Hicks; Carl D Langefeld; Rulan S Parekh; Donald W Bowden; Barry I Freedman
Journal:  Am J Kidney Dis       Date:  2011-11-25       Impact factor: 8.860

2.  GWAS in Mice Maps Susceptibility to HIV-Associated Nephropathy to the Ssbp2 Locus.

Authors:  Nicholas J Steers; Yask Gupta; Vivette D D'Agati; Tze Y Lim; Natalia DeMaria; Anna Mo; Judy Liang; Kelsey O Stevens; Dina F Ahram; Wan Yee Lam; Mihai Gagea; Lalitha Nagarajan; Simone Sanna-Cherchi; Ali G Gharavi
Journal:  J Am Soc Nephrol       Date:  2021-12-10       Impact factor: 10.121

3.  A transcriptional network underlies susceptibility to kidney disease progression.

Authors:  Denise Laouari; Martine Burtin; Aurélie Phelep; Frank Bienaime; Laure-Hélène Noel; David C Lee; Christophe Legendre; Gérard Friedlander; Marco Pontoglio; Fabiola Terzi
Journal:  EMBO Mol Med       Date:  2012-06-18       Impact factor: 12.137

4.  Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice.

Authors:  Rachel L Berry; Derya D Ozdemir; Bruce Aronow; Nils O Lindström; Tatiana Dudnakova; Anna Thornburn; Paul Perry; Richard Baldock; Chris Armit; Anagha Joshi; Cécile Jeanpierre; Jingdong Shan; Seppo Vainio; James Baily; David Brownstein; Jamie Davies; Nicholas D Hastie; Peter Hohenstein
Journal:  Dis Model Mech       Date:  2015-05-14       Impact factor: 5.758

5.  Refinement of the HIVAN1 Susceptibility Locus on Chr. 3A1-A3 via Generation of Sub-Congenic Strains.

Authors:  Natalia Papeta; Ami Patel; Vivette D D'Agati; Ali G Gharavi
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

6.  Lack of APOL1 in proximal tubules of normal human kidneys and proteinuric APOL1 transgenic mouse kidneys.

Authors:  Natalya A Blessing; Zhenzhen Wu; Sethu M Madhavan; Jonathan W Choy; Michelle Chen; Myung K Shin; Maarten Hoek; John R Sedor; John F O'Toole; Leslie A Bruggeman
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

7.  APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.

Authors:  Leslie A Bruggeman; Zhenzhen Wu; Liping Luo; Sethu Madhavan; Paul E Drawz; David B Thomas; Laura Barisoni; John F O'Toole; John R Sedor
Journal:  PLoS One       Date:  2019-10-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.